Friday, September 12, 2025

Latest

Market Movers: FSD Pharma Climbs 46% in Intraday Trading

FSD Pharma (CSE: HUGE) has experienced a massive run up this week on the back of news that it will soon be cross listed on the Nasdaq exchange in the US. The equity had ran as far as $14.50 today, before giving back a significant portion of the gains as long term shareholders look to exit on the run-up. The equity closed Friday’s session at $7.40.

FSD Pharma Logo

Materially, little has changed over the last 48 hours for the equity. While the firm announced that it has been approved for listing on the Nasdaq as of Thursday morning, nothing related to the performance of the company itself has changed.

The most recent monthly report filed for the month of December confirms that little has changed materially for the company over the last month as well, outside of the dual listing. The most text attributed to the monthly report was routine updates on the six currently outstanding lawsuits and legal battles the firm is involved within, the majority of which are related to matters of non-payment.

The largest developments of late for the firm consist of continuous changes to management and advisory boards, which includes some internal shuffling as well. The firm has added a number of medical doctors to its advisory boards as of late, in an attempt to turn the story from that of a cultivator of cannabis to a cannabis pharmaceutical focused firm.

On the equity side of things, 27,580 securities were issued to US resident directors of the firm on Monday as compensation for services. It should also be noted that the recent run up has been on relatively low volume – yesterdays 20.2% gain was via total volume of 87,864. Today’s run-up meanwhile was on slightly more volume of 198,000 at the time of writing as per TradingView. StockWatch gives a higher value of 300,000 shares traded, which may include what is often referred to as the “dark pool” trades.

The big push however, which took the equity from $11.75 to $14.00 in the span of an hour, occurred on a very light volume of 37,900 shares being traded – which is also likely why the equity has since begun giving up those gains. Nevertheless, Thursday’s open for the equity on the Nasdaq exchange is likely to cause fireworks in any event – the direction of which, is currently undecided.

FSD Pharma last traded at $13.06 on the CSE, up 46.74% on the day.


Information for this briefing was found via Sedar, and FSD Pharma. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Avino Q2 Earnings: Steady As She Goes

MEG Energy: Cenovus Comes In With $7.9 BILLION Offer

Orla Mining Q2 Earnings: Musselwhite Changes Everything

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

FSD Pharma Issues Additional Shares To Solarvest BioEnergy

FSD Pharma (CSE: HUGE) (NASDAQ: HUGE) announced this morning that the firm has signed an...

Tuesday, February 4, 2020, 08:52:51 AM

FSD Pharma Announces 1 for 201 Share Consolidation

FSD Pharma (CSE: HUGE) announced this morning that it will be completing a share consolidation...

Friday, October 11, 2019, 09:04:28 AM

Cannara Biotech & Its Ties to FSD Pharma

Cannara Biotech (CSE:LOVE) is set to start trading today under the ticker symbol LOVE on...

Monday, January 14, 2019, 02:00:30 PM

FSD Pharma Severs Ties with Auxly Cannabis

FSD Pharma (CSE: HUGE, OTCMKTS: FSDDF) announced late last night that it had cut ties...

Thursday, February 7, 2019, 02:00:36 PM

Is FSD Pharma Really so Huge?

FSD Pharma Inc (CSE: HUGE, OTCMKTS: FSDDF) is for all intents and purposes focused solely...

Thursday, December 13, 2018, 02:00:50 PM